Remote Radiopharma Medical Director - HCC/GI Dev

Bristol Myers Squibb; Lawrence Township (NJ); On-site; USD 307,000 - 372,000; Full time

Benefits offered by this job

Health Coverage

Wellbeing Support

Financial well-being

Job summary

RayzeBio, a wholly-owned subsidiary of Bristol Myers Squibb, is seeking a Sr Medical Director of Clinical Development for Radiopharmaceuticals in HCC and GI cancers to oversee IND through Phase 3 programs. You will collaborate with BMS oncology leaders to develop strategies across RayzeBio portfolios and supervise cross-functional study teams.

The role requires an MD with oncology subspecialty and 5+ years in oncology clinical development, with expertise in HCC/GI cancers, and strong leadership.

Qualifications

• MD with sub-specialty training in oncology and 5+ years of pharmaceutical/biotech experience in oncology solid tumor clinical development is required.
• Expertise in HCC and/or GI cancers is required.

Responsibilities

• Support IND preparation and regulatory authority interactions.
• Design and execution of Phase 1 to Phase 3 clinical trials and medical monitoring.
• Lead cross-functional study teams responsible for design, implementation, monitoring, analysis, and reporting of trials.

Skills

Leadership

Cross-functional Collaboration

Clinical development

Regulatory knowledge

Education

MD with oncology subspecialty

Job description

RayzeBio, a wholly-owned subsidiary of Bristol Myers Squibb, is seeking a Sr Medical Director of Clinical Development for Radiopharmaceuticals in HCC and GI cancers to oversee IND through Phase 3 programs. You will collaborate with BMS oncology leaders to develop strategies across RayzeBio portfolios and supervise cross-functional study teams.

The role requires an MD with oncology subspecialty and 5+ years in oncology clinical development, with expertise in HCC/GI cancers, and strong leadership.